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Triggering Doxorubicin Release from Responsive Hydrogel Films by
Polyamine Uptake†
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Polyamines such as putrescine, spermidine and spermine are required in many inter- and intra-cellular
processes. There is, however, evidence of anomalously high concentrations of these polyamines
around cancer cells. Furthermore, high polyamine concentrations play a key role in accelerating
the speed of cancer proliferation. Some current therapies target the reduction of polyamine con-
centration to delay cancer advance. In this study, we use a molecular theory to proof the concept
that poly(methacrylic acid) (PMAA) hydrogels can play the dual role of incorporating and retain-
ing polyamines as well as releasing preloaded drugs in response. To such goal, we have developed a
molecular model for each of the chemical species, which includes the shape, size, charge, protonation
state, and configuration. Our results indicate that PMAA hydrogel films can incorporate significant
amounts of polyamines; this absorption increases with the solution concentration of polyamines.
Doxorubicin was chosen as a model drug for this study, which can be successfully incorporated
within the film; the optimal encapsulation conditions occur at low salt concentrations and pH values
near neutrality. Polyamine absorption within the film results in the desorption of the drug from the
hydrogel. An increasing concentration of polyamines enhances drug release. To validate our theoret-
ical findings, poly(methacrylic acid) hydrogel thin films were synthesized by Atom Transfer Radical
Polymerization. Absorption/desorption experiments followed by UV-Vis spectroscopy demonstrate
doxorubicin encapsulation within these films and polyamine dependent drug release.
1 Introduction
Putrescine, spermidine and spermine are polyamines having two,
three and four amino groups, respectively, which are present in
all living cells. Polyamines are indispensable to cell growth and
required in many intra/inter-cellular processes. They participate
in diverse metabolic functions such as DNA replication, ion chan-
nels regulation, protein phosphorylation, and extracellular sig-
nalling1,2. Moreover, polyamines interact strongly with mem-
brane phospholipids, and may thus play an important role in the
regulation of membrane-linked enzymes3. The synthesis of these
essential molecules begins when the enzyme ornithine decarboxy-
lase (ODC) catalyzes the production of putrescine2,4,5.
In the surroundings of healthy cells, polyamines are found in
high micromolar to low millimolar concentrations6,7. Near tumor
cells, however, their concentration is relatively higher. Many stud-
ies have shown that cancer patients have increased polyamine
concentrations both in blood and urine8, which results from the
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higher activity of ODC2,9,10. Anomalous polyamine concentra-
tions can mark the presence of a tumor cell11,12, but also an ex-
cess polyamine availability can increase the speed at which tu-
mors spread and metastasize2. At the same time, such excess
can inhibit immune mechanisms that cell have in place to prevent
tumor spreading2,13. Indeed, patients with increased levels of
polyamine generally receive poorer prognosis2,14. There is cur-
rently great interest in cancer therapies that can regulate/reduce
the amount of polyamines in the vicinity of tumor cells to prevent
their spreading2,15–17. In this work, we propose and explore both
theoretically and experimentally the concept of a functional bio-
material capable of absorbing polyamines but at the same time
using the excess concentration of these markers near tumor cells
as a trigger for the release of a therapeutic drug.
Hydrogels of cross-linked polymer chains are currently consid-
ered for diverse applications to biomedical research18. For exam-
ple, biomaterials based on pH-sensitive hydrogels have been ex-
plored as oral drug delivery vehicles that have the potential to en-
capsulate and transport a therapeutic agent through the gastroin-
testinal tract, protecting the cargo from the acidic medium of the
stomach, and release it at the neutral environment of the small
intestines19–22. These hydrogels are responsive to pH changes
Journal Name, [year], [vol.], 1–11 | 1

































































because they contain a significant number of weak acidic groups.
Here, we will consider a poly(methacrylic acid) (MAA) hydrogel
film. Hydrogels of PMAA are capable of responding to diverse
biological stimuli, including changes in the physiological pH23.
In this context, our present contribution addresses a fundamen-
tal question: Is it possible to exploit the environment sensitive
properties of weak polyacid hydrogels in developing a bioma-
terial that can simultaneously incorporate/sequester polyamines
and release a therapeutic drug in response?
Doxorubicin is an anthracycline that is commonly used in
chemotherapy due to its efficacy in fighting a wide range of can-
cers such as carcinomas, sarcomas and hematological cancers24.
It is one of the most potent antineoplastic drugs with the experi-
mental advantage that it can be monitored by fluorescence and/or
absorbance25. Used alone or in combination with other thera-
peutic agents, Doxorubicin is currently the compound of its class
having the widest spectrum of activity26. In addition, because
it is positively charged, doxorubicin can be encapsulated within
anionic nanogels22 or immobilized at the surface of negatively
charged nanohydrid surfaces27.
The aim of this study is to characterize PMAA hydrogels as
materials that can capture polyamines and simultaneously re-
lease doxorubicin in response. To this goal, we apply a recently
developed molecular theory to investigate the absorption from
polyamines and doxorubicin solutions to PMAA hydrogel films.
This theory is formulated on the basis of a general thermody-
namic potential that accounts for the free energy cost of protona-
tion/deprotonation of titratable units, the entropic loss of molec-
ular confinement, the conformational and translational degrees
of freedom of both the polymer layer and the absorbates, and
the electrostatic and steric interactions. Our molecular model in-
cludes size, shape, configuration, and local charge-state descrip-
tion of all chemical species present in the system (spermidine,
spermine, putrescine, doxorubicin and the PMAA network).
Finally, PMAA films were synthesized, and by choosing a set of
representative conditions from the entire theoretically-explored
collection, we have performed polyamines and doxorubicin ab-
sorption experiments followed by UV-Vis technique. These exper-
iments demonstrate the suitability of the present approach to ex-
plore new biomaterials and its response in the context of cancer
applications. In summary, here we explore the physicochemical
behavior of the hydrogels from a theoretical perspective, which
allows for a systematic study of its response to changes in pH,
salt and polyamine concentration, and also from an experimental




The system that we study is schematized in Fig. 1. A surface-
grafted cross-linked poly(methacrylic acid) network is in equilib-
rium with a solution containing water molecules, hydronium and
hydroxide ions, and sodium chloride, which is completely disso-
ciated into chloride and sodium ions. In addition, this solution
contains either doxorubicin or a polyamine or both species. The
Fig. 1 The scheme presents the system of study and illustrates the
coarse grain model employed to describe the different chemical species. A
surface-grafted cross-linked PMMA network is in contact with an aqueous
solution that can contain doxorubicin and/or one of the polyamines.
polyamines we have considered are putrescine, spermidine and
spermine.
To study this system we apply a molecular theory that was re-
cently developed to investigate absorption to such pH-responsive
hydrogel films from protein mixtures28,29. Our approach is based
on the work of Szleifer and collaborators to study the behavior
of grafted weak polyelectrolyte layers30,31. The method here em-
ployed is general and flexible; it has for example been applied for
the study of glyphosate sequestration in poly(allyl amine) hydro-
gels32.
Next, we will present a concise description of the theory with
emphasis in the molecular model introduced to describe doxoru-
bicin, putrescine, spermidine and spermine. A full description of
this molecular model can be found in our previous work28.
The first step is the formulation of a general free energy includ-
ing all the relevant contributions:








where T is the system temperature, and Scon f ,nw is the network’s
configurational entropy; this contribution results from the differ-
ent molecular conformations that the cross-linked polymer can
assume. The chemical free energy that describes the protonation
equilibrium of titratable units of the network is Fchm,nw. The mix-
ing entropy of the small mobile species is Smix, which describes
the translations of water molecules, hydronium, hydroxide and
salt ions.
The sum in the second line of Eq. (1) considers the free energy
contributions from the absorbates. The subindex i runs over the
absorbates in the solution: doxorubicin and/or putrescine, sper-
midine and spermine (we consider solutions having either the
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drug or a polyamine as well as solutions having both). For each
of these species, Str,i and Scon f ,i are its translational and config-
urational entropy, while Fchm,i is the chemical free energy of its
protonable units. The energetic contributions to the free energy
include steric repulsions (at the excluded-volume level), Uste, and
the electrostatic interactions, Uelec.
Each of these contributions to the free energy can be written as
a functional of a few functions: (i) the probability distribution of
network conformations, (ii) the local (position dependent) den-
sities of all mobile species, (iii) the local degree of charge of all
titratable units, including those of the polymer network and those
of the absorbates, and (iv) the local electrostatic potential.
The free energy functional is then minimized with respect to
each functions (i)-(iv). In performing this step, we consider that
the proper thermodynamic potential whose minimum yields the
equilibrium conditions is the semigrand potential, which is a func-
tion of the chemical potentials of the free species.
This procedure allows for expressing functions (i)-(iii) in terms
of two unknown local potentials: the osmotic pressure and the
electrostatic potential. These potentials can be obtained solving
the solution incompressibility constraint and the Poisson equa-
tion.
To solve these equations we use some approximations: a ho-
mogeneous system in the plane of the surface that supports the
film (x− y plane) is considered. Changes occur along the normal
direction to that plane, where z is the coordinate that measure
the distance from the supporting surface. While the grafting sur-
face sits at z = 0, z→∞ corresponds to the bulk solution, which is
homogeneous. The solutions to the system of non-linear coupled
differential equations that result from minimizing the free energy
are obtained numerically using a Newton-Krylov method with a
space discretization of 0.5nm along the z-direction.
2.1.2 Molecular Model
Fig. 2 Average net charge number of doxorubicin and the polyamines
as a function of pH in dilute solutions. The right-hand side axis gives
the degree of charge of an isolated methacrylic acid unit. The vertical
dash-dotted line indicates physiological pH. (Theoretical predictions.)
Our theoretical formalism requires a molecular representation
of all chemical species in the system. Figure 1 includes the
coarse grain scheme used for MAA and the species in solution.
Polyamines (putrescine, spermidine and spermine) are repre-
sented using their different amine groups (N1 to N5). Doxoru-
bicin model includes the rings (D1, D2 and D4) as well as the car-
boxylic group (D3). The volume, pKa and charge of these groups,
and those of water molecules and ions, are presented in Table 1.
The molecular geometries as well as the pKa values assigned to
the different coarse grain units have all been obtained from the
literature9,33,34.
The polymer network is made of 50-segment long cross-linked
chains; each chain segment is a coarse grain representation of
a MAA unit (see Fig. 1). This network has diamond-like topol-
ogy with the cross-linking units having coordination four35–38.
Network conformations are generated using Molecular Dynamics
simulations as described in Hagemann et al. 28 .
With the above described pKa scheme, Fig. 2 shows the aver-
age electric charge of each polyamine and that of doxorubicin.
The graph also displays the degree of charge of an isolated MAA
monomer in dilute solution. The driving force for absorption are
the absorbate-MAA electrostatic attractions. The positive charge
of all the absorbates decreases with increasing pH. The polymer
becomes more negatively charged with increasing pH. Then, we
expect absorption to be a nonmonotonic function of the solution
pH. In addition, the isoelectric point of doxorubicin is around
neutral pH, which implies that the drug is charge neutral at phys-
iological conditions and negatively charged at higher pH values.
In Section 3, we will discuss the role of doxorubicin charge regu-
lation in its absorption/desorption in/from the hydrogel.
CG unit pKa q v (nm3)
N1 9.9 (+1) 0.051
N2 10.9 (+1) 0.051
N3 8.4 (+1) 0.063
N4 7.9 (+1) 0.063
N5 10.1 (+1) 0.051
D1 - 0 0.085
D2 7.34 (-1) 0.085
D3 8.46 (-1) 0.035
D4 9.46 (+1) 0.085
MAA 4.65 (-1) 0.065
H2O - 0 0.03
H3O+ - +1 0.03
OH− - -1 0.03
Na+ - +1 0.033
Cl− - -1 0.033
Table 1 Coarse grain model. The pKa values assigned to the different
coarse grain units have all been obtained from the literature9,33,34, and
the molecular volumes correspond to Van der Waals values. () indicate
the charge of the ionized chemical species.
2.2 Experiments
In order to support the theory and molecular modelling, cross-
linked polymeric films based on poly(methacrylic acid) have been
prepared and experiments of doxorubicin loading and release in
presence of spermine and spermidine have been carried out. Con-
tact angle of the film at each step was measured to follow the
synthetic procedure.
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Fig. 3 Steps of the thin PMAA film synthesis, represented as: A) ATRP initiator on substrates; B) t-BMA film growth; C) hydrolysis of t-BMA.
Contact angle measurements can be found in the ESI, which confirm successful substrate modification after each step.
2.2.1 Controlled growth of PMAA thin film
Thin PMAA films were obtained by Atom Transfer Radical Poly-
merization (ATRP) technique, which allows the surface-initiated
polymerization. The complete PMAA film synthesis requires three
main steps as represented in Fig. 3. These steps are: 1) grafting of
ATRP initiator on substrates (Glass coverslips and single-polished
silicon wafers); 2) ATRP procedure using ter-butyl methacrylate
(t-BMA) and N,N’-Methylenebisacrylamide (BIS) as the cross-
linker; and 3) hydrolysis of the resulting cross-linked ter-butyl
methacrylate films with trifluoroacetic acid to obtain the PMAA
films.
1) ATRP initiator on substrates. After cleaning with soapy wa-
ter, ethanol and acetone in a ultrasonic bath, glass coverslips
and silicon wafers were modified by immersion in a solution
2% v/v of 2-bromo-2-methyl-N-(3-(triethoxysilyl)propyl) prope-
namide (prepared as previously reported39) in dry ethanol for 1
hour at 30◦C. The substrates were then washed with ethanol and
cured for 2 h in an oven at 60◦C under vacuum. The measured
contact angle (Ramè-Hart Contact Angle goniometer model 290)
using water was around 63.6◦± 0.1◦ without changes over time,
slightly lower than for the glass slide (64.7◦± 0.2◦). The full set
of measurements is shown in the Electronic Supplementary Infor-
mation (ESI).
2) Ter-butyl methacrylate film growth. The ATRP polymeriza-
tions were carried out according to Brown et al. 40 . A solution of
t-BMA (15 ml, 92 mmol, Aldrich 98%), BIS (422 mg, 2.76 mmol,
Aldrich 99%), CuBr2 (4.1 mg, 0.018 mmol, Aldrich 99.999%),
and N,N,N,N,N-Pentamethyldiethylenetriamine (PMDETA, 0.12
ml, 0.55 mmol, Aldrich, 99%) dissolved in DMSO (15 ml) was
degassed by N2 bubbling for an hour at room temperature. Then,
CuBr (26.5 mg, 0.18 mmol, Aldrich 99.999%) was added and the
mixture was left under N2 for 15 min. Simultaneously, initiator
substrates were sealed in Schlenk tubes and degassed through
vacuum/N2 cycles. Then, the reaction mixture was syringed into
these Schlenk tubes to cover completely the samples. The mixture
was left 24 h under N2 and the substrates were then removed and
washed with DMSO, acetone and dried with N2. The measured
contact angle was 89.3◦±0.1◦ without changes over time.
3) Hydrolysis of obtained cross-linked ter-butyl methacrylate.
Cross-linked PtBMA films were immersed in a solution of Triflu-
oroacetic Acid (Aldrich 99%) in CH2Cl2 (50% v/v) for one hour
at room temperature. The substrates were then washed with wa-
ter several times and were left immersed in water 10 minutes
and dried with N2. The measured contact angle using water de-
creased over time, from an initial value around of 69◦ to 63◦; this
behavior indicates a successful hydrolysis of the PtBMA film into a
more hydrophilic PMAA film, exposing carboxylic moieties, which
is swelling/hydrating over time.
2.2.2 Doxorubicin loading and release in presence of
polyamines
The doxorubicin (Doxo, Aldrich 98.0-102.0% in doxorubicin hy-
drochloride) loading was performed immersing the PMAA films
in a 10−2 M solution of the drug in ultrapure Milli-Q water
(18.2MΩcm) during 24 h in the fridge (see Fig. 4). Using a UV-Vis
Lambda 35, Perkin Elmer spectrometer, the absorption bands of
Doxo in the 450−550nm were used to characterize its loading in
the film. To such end, after loading, the substrates were immersed
for a few seconds in ultra pure water to remove surface-attached
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Fig. 4 Scheme showing doxorubicin loading to the PMAA hydrogel film and release in presence of spermidine∗∗.
molecules and dried under a N2 stream. Finally, the substrates
were placed vertically in the optical path of the spectrometer and
the scans were performed, covering the 200-800 nm range, with
a 480 nm/min scan rate and a slide width of 1 nm.
The release was performed by immersing the loaded substrates
either in water or in solutions of spermidine (Aldrich > 99%) or
spermine (Aldrich > 97%), each at 2.8% w/v (see Fig. 4) at differ-
ent times. The release was followed in the same way as the load-
ing. These polyamine solutions were neutralized with sodium
hydroxide 0.1 M, which increased the ionic strength from pure
water and lead to a final pH of 7. All the experiments were per-
formed using ultrapure Milli-Q water. Polyamine concentration
was chosen in order to explore a saturation regime, equivalent to
the extreme of the explored region in the theoretical predictions
(see below). In this way, equivalent amine loading quantities can
be qualitatively compared.
3 Results and Discussion
3.1 Theoretical Results
The first question that we address is how PMAA hydrogels re-
spond to polyamine solutions. Our thermodynamic approach al-
lows for considering the absorption inside the polymer network







where the coordinate z measures the distance from the surface
that supports the film, and the subindex i refers to the absorbate
of interest. The local function ρi(z) is the density of the absorbate,
and ρbulki = limz→∞ ρi(z) is that of the bulk solution, far from the
hydrogel film. This definition of Γ quantifies the mass of absorbed
molecules per unit area in excess of the contribution imposed by
the bulk solution. The expression given by Eq. (2) describes the
absorption of each of the amines, but it is also valid for doxoru-
bicin.
Figure 5 shows absorption isotherms for each of the polyamines
as a function of its concentration in the bulk solution. Be-
cause there are reports that the surroundings of tumor cells are
∗∗This scheme does not describe the swelling behavior of the hydrogel film.
acidic41–46, we include absorption isotherms for different pH val-
ues. We emphasize that our fist objective is to investigate the ca-
pacity of PMAA hydrogels to sequester polyamines at physiologi-
cal conditions; then, the results of Fig. 5 correspond to solutions
without doxorubicin and 100mM of [NaCl]. As expected, absorp-
tion increases with increasing concentration of polyamines. This
is an indication of a non-saturated regime being achieved with the
explored concentration, which is easily seen from the absorption
isotherms.
Further on, near healthy cells, polyamine concentration is in
the range from 10−4 to 10−3 M, which can increase one order of
magnitude or more around tumors2. The results of Fig. 5 sug-
gest that PMAA hydrogels can respond to these conditions by cap-
turing increasing amine quantities. In particular, putrescine dis-
plays a seemingly on/off behavior around the onset of the healthy
to pathological concentrations. In addition, except for the most
acidic solutions (pH 5), this absorption behavior holds for dif-
ferent pH values around physiological conditions, which points
to the hydrogel’s ability to adapt to small pH changes caused by
damaged cells.
Absorbed polyamines are distributed more or less homoge-
neously within the hydrogel film (see ESI). Such distribution how-
ever is correlated with the polymer density: higher concentra-
tions of polyamine are found in the regions of locally high vol-
ume fraction of PMAA (see ESI). Therefore, polyamines have a
higher probability of being found near network cross-links, which
is where the highest polymer density occurs. Similar behavior
has been predicted by Sai et al. 47 using molecular dynamics
simulations, who suggested that chromophore amphiphiles self-
assembly at the nodes of chemically cross-liked polyelectrolyte
hydrogels.
Under similar conditions, the hydrogel absorbs more spermine
than spermidine and putrescine (compare panels A, B and C of
Figure 5, respectively), which can be explained on the basis of
the net positive charge of the polyamines: the more charged the
amine is, the more it absorbs to the film because a higher positive
charge reduces the entropic cost of counterion confinement while
allowing for the electrostatic attractions with the MAA polymer.
Schimka et al. 48 have studied the interaction between poly-
mer microgels and light-sensitive surfactants with synthetic
polyamines as head groups. These surfactants have different
Journal Name, [year], [vol.], 1–11 | 5

































































Fig. 5 Plot of the absorption, Γ, of spermine (A), spermidine (B) and putrescine (C) as a function of its (bulk) solution concentration. The various
curves in each panel correspond to different pH values (around 7) and physiological salt conditions, [NaCl] = 100mM. Shaded regions indicate the
range of healthy polyamine concentrations2. There is no doxorubicin in these solutions. (Theoretical predictions.)
numbers of amino groups with charges between +1 and +3. The
anionic microgels deswell when exposed to a sufficiently high
concentration of surfactant (depending on the isomerization state
of the surfactant). Their study shows both experimentally and
theoretically that a larger concentration of surfactant is needed
to trigger microgel deswelling when decreasing the charge of the
polyamine head group. Such behavior indicates that increasing
the number of amino groups facilitates surfactant uptake by the
microgel, in agreement with our results.
Fig. 6 Color map showing the absorption of doxorubicin (see Eq. (2))
as function of the composition of the solution that embeds the hydrogel,
i.e., pH and [NaCl]; the concentration of the drug in the solution is
[Doxo] = 1mM. (Theoretical predictions.)
Next, we consider the ability of PMAA hydrogel films to incor-
porate doxorubicin (Doxo). Hydrogels of cross-linked polyacid
chains are sensitive to changes in solution ionic strength or salt
concentration49. This behavior may be not be relevant in bio-
logical environments with highly regulated concentration of ions,
but controlling salt concentration is critical in the lab to enhance
loading the therapeutic agent inside the material. Then, we have
considered doxorubicin absorption for typical lab conditions, cov-
ering a wide range of pH and [NaCl], as opposed to physiological
conditions.
Figure 6 shows the excess absorption of Doxo, calculated using
Eq. (2). This graph highlights the effect of decreasing salinity to
boost drug absorption. Because doxorubicin charge is +1 (at low
pH), its absorption competes with that of sodium ions to neutral-
ize the charge of the polymer. Therefore, the best conditions for
its incorporation into the film correspond to reducing the avail-
ability of salt counterions.
Fig. 7 Plot showing doxorubicin charge number inside the PMAA network
as a function of pH, for different salt concentrations (solid lines) as well
as the average charge of the molecule in the bulk solution (dashed line);
[Doxo] = 1mM. (Theoretical predictions.)
In our model doxorubicin has its isoelectric point (pI) at pH
7.8. Interestingly, Fig. 6 shows that the optimal conditions for the
electrostatically-driven absorption occurs at pH values near pI.
This result can be explained considering that pH drops inside the
film (see ESI), effect that has been predicted for the interior of a
variety of charged polymeric systems from single chains, grafted
polymer layers, star-like polyelectrolytes, to gels having different
topologies30,50–53. This effect results in charge regulation, partic-
ularly from the diphenolic group of doxorubicin (see D2 in Fig. 1
with pKa 7.3), which protonates upon absorption. Inside the film,
absorbed Doxo molecules are more positively charged, on aver-
age, than in the solution; this behavior is described in Fig. 7. At a
fixed pH, the effect of lowering the solution salt concentrations is
increasing the average charge of the absorbed molecules. In par-
ticular, the (apparent) pI of absorbed Doxo can increase several
units in this way.
Next, we evaluate if doxorubicin can be released from the hy-
drogel when the material is in contact with polyamine solutions.
Figure 8 shows Doxo absorption in the film from solutions that
contain different concentrations of polyamines. As a reference,
the graphs also include the absorption of doxorubicin from solu-
tions containing no polyamines. We again consider physiological
[NaCl] = 100mM but extend the range of pH values to describe
6 | 1–11Journal Name, [year], [vol.],

































































Fig. 8 Plot of the absorption of doxorubicin (see Eq. (2))as a function of pH for solutions containing spermine (A), spermidine (B) and putrescine
(C). In each panel, the various solid-line curves correspond to solutions having different concentration of the polyamine, while the dashed-line curve
corresponds to a solution without polyamines. All results correspond to 1mM Doxo and 100mM NaCl solutions. (Theoretical predictions.)
Fig. 9 Plot showing Doxo retention, Γret (see Eq. (3)), as a function of
the concentration of amines for solutions having 100mM NaCl and pH 6
(top panel) pH 7 (bottom panel). (Theoretical predictions.)
conditions that might occur around acidic diseased tissue. Dox-
orubicin absorption is a nonmonotonic function of the solution
pH, with a maximum between 6 and 7. This nonmonotonic be-
havior was to be expected since the net negative charge of the
polymer is an increasing function of the solution pH (see Fig. 2),
while the positive average charge of Doxo decreases until eventu-
ally turning negative at sufficiently high pH values (see Fig. 7).
Doxorubicin absorption decreases when polyamines are
present in the solution (compare the different solid-line curves of
Fig. 8 to the dashed-line curve in each panel), which results from
polyamine capture as described in Fig. 5. This decrease in Doxo
absorption with respect to solutions without the drug can be in-
terpreted as a release from the film. Spermine being the strongest
charged is the most efficient in preventing Doxo absorption (see
Fig. 10 Doxorubicin loading to and release from PMAA films in water,
represented as the change in absorbance (at λ = 490 nm) relative to the
initial loading at different release times. Inset: Plot of the UV-Vis spectra
of PMAA films after 24 h in contact with Doxo (red; t = 0). The various
curves illustrate drug release after different release times to water. The
black curve is included as a reference and corresponds to the signal of
the bare glass support. AG: Glass substrate absorbance; A0: Fully loaded
hydrogel absorbance.
panel A of Fig. 8).
To further quantify how the drug desorbs from the hydrogel
film when amines are incorporated into the solution, we define





where Γret is Doxo retention, ΓDoxo([Amine]) is the doxorubicin
absorption for amine solutions (see solid-line curves in Fig. 8),
and Γ0Doxo = ΓDoxo([Amine] = 0) is that for solutions without
polyamines (see Fig. 6 and dashed-line curves in Fig. 8).
Figure 9 shows Doxo retention in presence of each of the
polyamines at physiological conditions as well as pH 6. If all the
drug is kept inside the film for a polyamine solution, then Γret ≈ 1;
while Γret ≈ 0 indicates that all the drug has been released. Neg-
ative values of Γret can occur because Γdoxo([Amine]), which is a
bulk excess quantity, can take negative values, which indicates
that under those conditions the amines prevent Doxo absorption
in the film.
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Fig. 11 Schematic representation of Doxo release by polyamine uptake (A). Doxorubicin loading to and release from PMAA films in spermine (B) and
spermidine (C) solutions represented as the change in absorbance (at λ = 490nm) relative to the initial loading at different release times. AG: Glass
substrate absorbance; A0: Fully loaded hydrogel absorbance.
Retention of doxorubicin within the hydrogel decreases as the
concentration of polyamine rises. This is true for all the amines,
and for pH 7 and 6 (see Figure 9). As aforementioned, spermine
is the most efficient in promoting Doxo release from the hydrogel.
At high amine concentrations, however, all polyamines can drive
the release of significant quantities of doxorubicin.
3.2 UV-Vis Spectra
Doxorubicin loading in the hydrogel was characterized by UV-Vis
experiments, analyzing the absorbance at λ = 490 nm. To ad-
dress the Doxo release after exposure to water, absorbance data
was normalized accordingly, by subtracting the glass substrate ab-
sorbance (AG) and then dividing by the absorbance of the fully
loaded hydrogel (A0), also with the AG subtracted. Figure 10
shows the relative change in the absorbance after a given re-
lease time for a hydrogel previously loaded during 24 h. The
inset shows the UV-Vis spectra after different release times in wa-
ter. The experimental results at t = 0 (the red spectra shown in
the inset of Fig. 10) evidence that the PMAA films incorporate
doxorubicin within their polymeric network. The absorbance at
λ = 490nm for that spectra correspond to the red bar in the main
figure. After sufficiently a long exposure time to water, the re-
lease from the films is only partial, demonstrating the affinity of
the drug to the film. However, there is a clear and significant ini-
tial drug release within the first 10 minutes, behavior that is not
observed in the subsequent release stages, where measurements
collapse to the same spectra (see the inset of Figure 10).
Doxo release can be triggered by exposing the hydrogel film
to polyamines, as depicted in Figure 11A. In order to evaluate
this behavior, release experiments were performed using spermi-
dine and spermine as model polyamines. Figure 11 shows the
changes in relative absorbance for the PMAA films loaded with
Doxo and its release in contact with spermidine (panel B) and
spermine (panel C) solutions at different exposure times. Pu-
trescine was not considered in the experiments due to the low
absorption that presents in comparison with spermine and sper-
midine (see Fig. 5). The results show that the release of the drug
in the presence of these polyamines is faster than in water, which
supports the predictions of our theory and molecular modeling:
PMAA hydrogels act as absorption platforms for polyamines, and
such incorporation can trigger the release of a previously loaded
drug.
Figure 11 B and C show that the release in the presence of
spermine is faster than upon spermidine incorporation: after a
15 seconds exposure to spermine, there is no longer UV signal
from Doxo, while a three times longer contact with spermidine is
required to reach the same release stage. In addition, the mag-
nitude of Doxo release using spermidine is less significant as op-
posed to the near complete release induced by spermine. These
results indicate that the number of amino groups determines its
retention in the hydrogel film, which is in line with the predictions
from our molecular theory (see Fig. 9) and the work of Schimka
et al. 48 .
After the loading of polyamines and the concomitant Doxo re-
lease, the PMAA films were exposed to a fresh Doxo solution,
to evaluate whether or not the absorption of polyamines would
prevent doxorubicin re-absorption, as depicted in Fig. 12A. In
other words, these experiments aim to answer if once released by
polyamine absorption, doxorubicin would again be absorbed by
8 | 1–11Journal Name, [year], [vol.],

































































Fig. 12 (A) Schematic representation of Doxo re-loading/release after
polyamine absorption. (B) The change in absorbance (at λ = 490nm)
relative to the initial Doxo loading in the hydrogel film (dashed line). AG:
Glass substrate absorbance; Ah: Absorbance for the initial Doxo loading
in the hydrogel film (before polyamine absorption).
the hydrogel, decreasing its concentration in the medium. In line
with the expected behavior, spermine retention by the hydrogel
film significantly hinders Doxo re-absorption within the polymeric
network (see Fig. S6 in the ESI). On the contrary, spermidine-
loaded hydrogel films in contact with Doxo show the possibility
to reload the drug, suggesting a different interaction intensity, de-
pending on the polyamine. As shown in the panel B of Fig. 12,
spermidine allows an initial reloading of Doxo into the film, but
this loading is easily released to the media, as compared to the
results of Fig. 10, where even after 1 hour of exposure to water,
Doxo is not released. These results also highlight the stronger in-
teraction of spermine (as compared to spermidine) with the poly-
meric network.
In summary, our experimental and theoretical results show the
potentiality of hydrogel films based on PMAA to load therapeu-
tic drugs, which was explored using Doxorubicin as model drug.
While the hydrogel performs as a controlled release platform, the
presence of high concentrations of polyamines in the surrounding
media can trigger drug release by interacting with the polymeric
network.
4 Conclusions
Polyamines are essential for cell metabolism as they are involved
in different cellular processes, serving as nutrients for cell growth.
In damaged cells that display uncontrolled growth, such as tu-
mors, there is a surge in the need for nutrients, which causes a
measurable excess in polyamine concentrations in the extracel-
lular compartments. This increase in polyamine concentration
plays a key role in the acceleration of tumor dissemination, and
it can serve as an indicator of cancer cells. Anomalous polyamine
concentrations can be the basis for therapies that target nutrient
removal and metastasis prevention as well as used in means to
evaluate the advance of a chemotherapy.
In this context, our goal in this work was to proof the following
concept: can PMAA-based hydrogels be employed for developing
biomaterials capable of both sequestering polyamines and deliv-
ering a therapeutic drug in response? We have developed a coarse
grain molecular model to describe doxorubicin, putrescine, sper-
midine and spermine. Using this molecular model and a thermo-
dynamic theory, our results provide insights into the absorption
of polyamines and doxorubicin in PMAA hydrogel films.
These results predict the ability of PMAA hydrogels to capture
increasing amounts of polyamines as the medium concentration
increases at physiological salt conditions. This absorption in-
creases with the number of amino groups; spermine displays the
strongest preference for the hydrogel. This behavior results from
the interaction between the positive charge of the amino groups
and the deprotonated (negatively charged) MAA segments.
We have considered the loading of an anti-cancer drug as dox-
orubicin to the PMAA hydrogel. The optimal encapsulation con-
ditions in the lab correspond to low salt concentration and pH
between 6 to 7. This result is counterintuitive as doxorubicin
isoelectric point is around neutral pH, which can be explained
by protonation of the drug upon absorption within the lower pH
medium inside the hydrogel.
When both doxorubicin and a polyamine are present in the so-
lution in contact with the hydrogel, the polyamines significantly
hinder drug absorption (as compared to solutions containing only
doxorubicin). This effect is enhanced as the solution concentra-
tion of polyamines increases. The efficiency in excluding the drug
from the film increases with the charge of the polyamine (i.e., the
number of amine groups); spermine is the most efficient of the
three amines considered in achieving this response. As we have
shown, this behavior can be interpreted as doxorubicin release
upon polyamine capture.
PMAA films were synthesized via Atom Transfer Radical Poly-
merization and characterized at specific conditions to support our
theoretical predictions. Doxorubicin absorption and release in
water, spermidine and spermine solutions were studied using UV-
Vis spectroscopy. These experimental results clearly support the
proposed concept of doxorubicin encapsulation within these films
and polyamine dependent drug release. Using the theoretical pre-
dictions of this work as a guideline, we are currently working on
a systematic characterization of the experimental system.
In summary, our combined theoretical and experimental stud-
ies indicate that hydrogels based on poly(methacrylic acid) have
Journal Name, [year], [vol.], 1–11 | 9

































































great potential to serve as the functional component in biomate-
rials that can capture polyamines and deliver a therapeutic drug
in response.
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